Please use this identifier to cite or link to this item:
|Title:||Janus kinase 2 negative polycythemia vera|
|Keywords:||Biochemistry, Genetics and Molecular Biology;Medicine|
|Citation:||Asian Biomedicine. Vol.9, No.5 (2015), 697-700|
|Abstract:||Background: A Janus kinase 2 (JAK2) mutation polycythemia vera (PV) is a common manifestation of stem cell disorder. However, available data on the clinical and treatment response of JAK2-negative PV patients are limited. Objectives: We report the case and clinical course of a patient with PV and left hemiparesis who was JAK2V617- negative. Methods: We conducted a literature review and compared our patient with previously published reports of JAK2-negative patients with PV. Results: Our patient presented with hemiparesis without a previous history of hematological disease. He was diagnosed with PV based on the British Committee for Standards in Haematology guidelines 2007. He underwent only phlebotomy with subsequent improvement of his neurological condition. He was discharged with therapeutic phlebotomy for one and a half months. Conclusions: Although this rare condition required complex diagnostic criteria, the patient achieved good clinical outcome with therapeutic phlebotomy alone.|
|Appears in Collections:||Scopus 2011-2015|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.